They can EASILY escalate in a combined P2B/P3 trial. IMO they have enough data to support the request at least. That would be the best way to proceed. And carrying other patients long term along the way from P2? Seriously?


IT EXCEEDED even my expectations.

Todays trading activity is complete BS from shorts and manipulators. Doubt Leo would have contacted Aspire unless the price were back over $2.